Newsroom

Newsroom

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

Press Release
Read More

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

Press Release
Read More

NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024

Press Release
Read More

ConcertAI & NeoGenomics Announce Collaboration to Advance Population-Scale, Definitive Hematological Research & Generative AI Solutions at 2024 JP Morgan Conference

Press Release
Read More

NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Press Release
Read More

NeoGenomics to Appeal Ruling

Press Release
Read More

RNA Fusions and Their Association with DNA Alterations in Myeloid Neoplasia Patients Identified By a Single Tube Multimodal Comprehensive Genomic Profiling Test

Literature
Read More

Longitudinal Neoadjuvant and Post-operative Evaluation of Circulating Tumor DNA in Early Breast Cancer Using a Tumor-Informed Assay: Updated Analysis of the TRACER Cohort

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients